Salix Expects Acquisition Of Oceana, Two Products, To Be Quickly Accretive
This article was originally published in The Pink Sheet Daily
Executive Summary
Although privately held Oceana’s two products – Solesta and Deflux – are regulated by FDA as Class III medical devices, Salix intends to market them with existing sales forces.